Ped Grand Rounds: Biology & Treatment of Rhabdomyosarcoma: Lessons from Children’s Oncology Group скачать в хорошем качестве

Ped Grand Rounds: Biology & Treatment of Rhabdomyosarcoma: Lessons from Children’s Oncology Group

Enduring Activity: 2021 Pediatric Grand Rounds “Biology and Treatment of Rhabdomyosarcoma: Lessons from the Children’s Oncology Group” Target Audience This activity is targeted toward all general pediatric physicians and pediatric subspecialists in the community. Statement of Need Pediatric grand rounds provide physicians a continuous update on emerging trends in caring for the pediatric patient, including new scientific discoveries that provide the underpinning of current pediatric practice. This activity will inform physicians about other issues involving professionalism, socioeconomic issues, and topics related to the ACMGE core competencies. Objectives At the conclusion of this offering, the participant will be able to: 1. Describe clinical and molecular features are used to guide risk-adapted therapy for rhabdomyosarcoma. 2. Describe the standard chemotherapy approaches used to treat rhabdomyosarcoma. 3. Describe the strategies used to identify novel agents to incorporate into rhabdomyosarcoma clinical trials. Faculty Douglas S. Hawkins, M.D. Seattle Children’s Hospital Center for Clinical and Translational Research Chair, Children’s Oncology Group Professor of Pediatrics, Hematology/Oncology Division Seattle Washington Faculty Disclosure Faculty for this course has no conflicts of interest to disclose. Planner Disclosure No planners for this course have conflicts of interest to disclose. Accreditation This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Norton Healthcare and the University of Louisville Department Of Pediatrics. Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Date of Original Release | August 2021 Course Termination Date | August 2023 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected] Resources Rhabdomyosarcoma https://pubmed.ncbi.nlm.nih.gov/30617... Insights into pediatric rhabdomyosarcoma research: Challenges and goals https://pubmed.ncbi.nlm.nih.gov/31222...